[posting]60899418[/posting]Erste FDA Entscheidung in 10 tagen falls die Zulassung erfolgt dürfte ein Kurssprung im bereich von $10-12 drin sein eventuell auch mehr .
------------------------
EM-100 Ophthalmic Solution
•Innovative over-the-counter ophthalmic solution for treatment of allergic conjunctivitis
•If approved, EM-100 would be the first preservative-free ophthalmic product indicated for allergic conjunctivitis
•Product has been filed with the FDA and is expected to be approved in 2019
•U.S. allergic conjunctivitis ophthalmic market is >$600 million annually
•Eton partnered with Bausch Health for commercialization
•Eton receives additional milestone payment upon approval and a royalty on net sales